[FG] Hartmann KarinHead of Research Unit Prof. Dr. med.Karin HartmannOverviewMembersPublicationsProjects & CollaborationsProjects & Collaborations OverviewMembersPublicationsProjects & Collaborations Projects & Collaborations 7 foundShow per page10 10 20 50 ANA/NORA Registry Research Project | 1 Project MembersInternational registry for patients with anaphylaxisMore information APEX Research Project | 1 Project MembersA phase 2 open-label, multicenter clinical study of the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib as a single agent in patients with advanced systemic mastocytosisMore information ECNM Registry Research Project | 1 Project MembersInternational registry for patients with mastocytosisMore information HARBOR Research Project | 1 Project MembersA randomized, double-blind, placebo-controlled phase 2/3 study of elenestinib in indolent systemic mastocytosisMore information PIONEER Research Project | 1 Project MembersA 3-part, randomized, double-blind, placebo-controlled phase 2 study to evaluate safety and efficacy of Avapritinib (BLU-285) in indolent and smoldering systemic mastocytosis More information SUMMIT Research Project | 1 Project MembersA multi-part, randomized, double-blind, placebo-controlled phase 2 clinical study of the safety and efficacy of bezuclastinib in subjects with nonadvanced systemic mastocytosisMore information TREATswitzerland Research Project | 1 Project MembersNational registry for patients with moderate-to-severe atopic dermatitis on systemic therapyMore information 1 1 OverviewMembersPublicationsProjects & Collaborations
Projects & Collaborations 7 foundShow per page10 10 20 50 ANA/NORA Registry Research Project | 1 Project MembersInternational registry for patients with anaphylaxisMore information APEX Research Project | 1 Project MembersA phase 2 open-label, multicenter clinical study of the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib as a single agent in patients with advanced systemic mastocytosisMore information ECNM Registry Research Project | 1 Project MembersInternational registry for patients with mastocytosisMore information HARBOR Research Project | 1 Project MembersA randomized, double-blind, placebo-controlled phase 2/3 study of elenestinib in indolent systemic mastocytosisMore information PIONEER Research Project | 1 Project MembersA 3-part, randomized, double-blind, placebo-controlled phase 2 study to evaluate safety and efficacy of Avapritinib (BLU-285) in indolent and smoldering systemic mastocytosis More information SUMMIT Research Project | 1 Project MembersA multi-part, randomized, double-blind, placebo-controlled phase 2 clinical study of the safety and efficacy of bezuclastinib in subjects with nonadvanced systemic mastocytosisMore information TREATswitzerland Research Project | 1 Project MembersNational registry for patients with moderate-to-severe atopic dermatitis on systemic therapyMore information 1 1
ANA/NORA Registry Research Project | 1 Project MembersInternational registry for patients with anaphylaxisMore information
APEX Research Project | 1 Project MembersA phase 2 open-label, multicenter clinical study of the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib as a single agent in patients with advanced systemic mastocytosisMore information
ECNM Registry Research Project | 1 Project MembersInternational registry for patients with mastocytosisMore information
HARBOR Research Project | 1 Project MembersA randomized, double-blind, placebo-controlled phase 2/3 study of elenestinib in indolent systemic mastocytosisMore information
PIONEER Research Project | 1 Project MembersA 3-part, randomized, double-blind, placebo-controlled phase 2 study to evaluate safety and efficacy of Avapritinib (BLU-285) in indolent and smoldering systemic mastocytosis More information
SUMMIT Research Project | 1 Project MembersA multi-part, randomized, double-blind, placebo-controlled phase 2 clinical study of the safety and efficacy of bezuclastinib in subjects with nonadvanced systemic mastocytosisMore information
TREATswitzerland Research Project | 1 Project MembersNational registry for patients with moderate-to-severe atopic dermatitis on systemic therapyMore information
